Capital World Investors Sells 1,884,881 Shares of Corteva, Inc. $CTVA

Capital World Investors decreased its position in Corteva, Inc. (NYSE:CTVA) by 8.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 21,355,189 shares of the company’s stock after selling 1,884,881 shares during the period. Capital World Investors’ holdings in Corteva were worth $1,431,438,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. JPL Wealth Management LLC purchased a new position in Corteva during the 3rd quarter valued at $25,000. Redmont Wealth Advisors LLC bought a new position in Corteva in the 3rd quarter worth $29,000. Basepoint Wealth LLC bought a new position in Corteva in the 4th quarter worth $30,000. Jackson Grant Investment Advisers Inc. raised its holdings in Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after purchasing an additional 213 shares in the last quarter. Finally, Measured Wealth Private Client Group LLC bought a new position in Corteva in the 3rd quarter worth $33,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of Corteva stock opened at $77.06 on Friday. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $51.54 billion, a P/E ratio of 45.33, a P/E/G ratio of 2.36 and a beta of 0.57. The business has a fifty day simple moving average of $81.17 and a two-hundred day simple moving average of $74.94. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CTVA. Wells Fargo & Company upped their price objective on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Berenberg Bank upped their price objective on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a report on Thursday, March 26th. Mizuho upped their price objective on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Argus upped their price objective on shares of Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a report on Tuesday, March 31st. Finally, Royal Bank Of Canada upped their price objective on shares of Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.